Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Antioxidants 9, 188
Nasal spray loses 60-70% of the peptide and produces slower, less consistent results
This is the sweet spot for many users, delivering 2.5 to 2.8mg GHK-Cu and 500 to 563mcg each of BPC-157, TB-500, and KPV
When administered therapeutically, GLP-1 receptor agonists work through several mechanisms: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner [1] [4] Suppressing glucagon release from alpha cells, reducing hepatic glucose output Slowing gastric emptying , which helps moderate post-meal blood glucose rises Promoting satiety through central nervous system pathways, potentially supporting weight reduction Investigational transdermal GLP-1 delivery systems typically utilise specialised technologies such as microneedles or active delivery methods rather than conventional patches, as GLP-1 molecules are large peptides that do not easily penetrate the skin barrier
It is intended for researchers, laboratories and procurement buyers reviewing melanocortin-related peptide research in controlled non-human research environments
